EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
19 hedge funds and large institutions have $89.7M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
48% less capital invested
Capital invested by funds: $174M → $89.7M (-$84.5M)
Holders
19
Holding in Top 10
4
Calls
$401K
Puts
–
Top Buyers
| 1 | +$3.6M | |
| 2 | +$2.21M | |
| 3 | +$90.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$56.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.32K |
Top Sellers
| 1 | -$152K | |
| 2 | -$117K | |
| 3 | -$28.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12K |
| 5 |
JP Morgan Chase
New York
|
-$6K |